“The treatment requires patients to carry mutations in their DNA repair genes, but more than 70% of patients do not carry these genes,” says Chunhong Yan, PhD.
“If retinopathy of prematurity is treated early, vision can be improved or saved, and we can protect the future of these infants,” says Yusra Zaidi, PhD.
"Funding is crucial for this type of research to be continued and for new and better treatments to be created," says Ali Arbab, MD, PhD.
"It's an engagement opportunity every single year our students are able to have that also serves one of the greatest needs in our region," says AU President Russell T. Keen.
“A patient’s immune system is unique. With clearer markers, we can better understand how to tailor therapies to each person’s condition," says Mohammad Oliaeimotlagh, MD.
"Having all of this in one place has really helped our patients take control of their care," says Raven Wells.
